There is research on this stock available only to PRO subscribers.
From other sites
PTN vs. ETF Alternatives
Palatin Technologies Inc is a biopharmaceutical company engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.
Other News & PR